drugset
Drugs / Jobelyn
last change Dec 2017 re-read 2 minutes ago

Jobelyn

Traditional medicine (herbal / TCM)

Developed for
schizophrenia · sickle cell disease
Investigated by
Federal Neuro-Psychiatric Hospital, Yaba · Lagos State University

Trials 2 · a red edge is where a trial was stopped

today NCT02240173 · Ph 1/2 NCT01703104 · Ph 1/2
2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02240173 Jun → Dec 2017 schizophrenia Federal Neuro-Psychiatric Hospital, Yaba Unknown No outcome recorded
Phase 1/2 NCT01703104 Jan → Mar 2012 sickle cell disease Lagos State University Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01704794 Comparator Apr 2013 → Apr 2014 sickle cell disease Lagos State University Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Jobelyn “Jobelyn is the proprietary name for the product intended to treat sickle cell disease and it is currently marketed as a nutritional supplement.” NCT01703104 ↗
2

“Jobelyn is a dietary supplement made from Sorghum bicolor” NCT02240173 ↗

NCT01704794 ↗
Action Inhibit “anti inflammatory effect with a selective COX 2 inhibition” NCT01704794 ↗
Modality Traditional medicine (herbal / TCM) “herbal nutritional supplement” NCT01704794 ↗